207 related articles for article (PubMed ID: 37900138)
21. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y
Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190
[TBL] [Abstract][Full Text] [Related]
22. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.
Sharad S; Ravindranath L; Haffner MC; Li H; Yan W; Sesterhenn IA; Chen Y; Ali A; Srinivasan A; McLeod DG; Yegnasubramanian S; Srivastava S; Dobi A; Petrovics G
Epigenetics; 2014 Jun; 9(6):918-27. PubMed ID: 24694733
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
24. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
[TBL] [Abstract][Full Text] [Related]
26. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
Sabherwal Y; Mahajan N; Zhang M
Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of Mycobacterium tuberculosis on interleukin-6 receptor 3'-untranslated region methylation in CD4
Mo SW; Zhu CZ; Liu XQ; Wan HQ; Li FX; Deng GF; Zhang ZD; Chen XC
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Apr; 45(4):379-386. PubMed ID: 35381636
[No Abstract] [Full Text] [Related]
29. Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer.
Zhang X; Wu M; Xiao H; Lee MT; Levin L; Leung YK; Ho SM
Prostate; 2010 May; 70(7):765-76. PubMed ID: 20054818
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
31. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
[TBL] [Abstract][Full Text] [Related]
32. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
[TBL] [Abstract][Full Text] [Related]
34. Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer.
Peter MR; Bilenky M; Davies A; Isserlin R; Bader GD; Fleshner NE; Hirst M; Zoubeidi A; Bapat B
Sci Rep; 2021 Mar; 11(1):6630. PubMed ID: 33758253
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of EphA5 by promoter methylation in human prostate cancer.
Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic regulation of androgen receptor gene expression in human prostate cancers.
Nakayama T; Watanabe M; Suzuki H; Toyota M; Sekita N; Hirokawa Y; Mizokami A; Ito H; Yatani R; Shiraishi T
Lab Invest; 2000 Dec; 80(12):1789-96. PubMed ID: 11140692
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
38. The transcription factor SPDEF suppresses prostate tumor metastasis.
Steffan JJ; Koul S; Meacham RB; Koul HK
J Biol Chem; 2012 Aug; 287(35):29968-78. PubMed ID: 22761428
[TBL] [Abstract][Full Text] [Related]
39. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
40. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
